- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 13-11-2025: Press Release
13-11-2025 | 04:43 pm
13-11-2025 | 04:43 pm
Zydus received USFDA final approval for Diroximel Fumarate capsules, targeting relapsing multiple sclerosis. The drug's annual US sales are USD 999.4 million, indicating a significant market opportunity.
No comments yet. Be the first to comment!